References
- GINA Executive Committee. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2019. Available from: www.ginasthma.org.
- Nannini LJ, Neumayer NS. Treatment step 1 for asthma should not be left blank, and SABA-only might not be a treatment step 1 option for asthma. Respiration. 2018;95(3):212–214. doi:10.1159/000484568.
- Nannini LJ. Overreliance link between asthmatic subjects and short-acting β2 agonists. Pulm Pharm Ther. June 2018;50:80–81. doi:10.1016/j.pupt.2018.03.003.
- Global Initiative for Asthma (GINA). Pocket guide for asthma management and prevention. Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute; 1998. Publication No. 95–3659B.
- O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017; 50:1701103. doi:10.1183/13993003.01103-2017.
- Nannini LJ. Treat to target approach for asthma. J Asthma. 2019:1. Published online 23 March doi:10.1080/02770903.2019.1591443.
- National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 2. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute; 1997. Publication No. 97–4051.
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. ESC Scientific Document Group. Eur. Heart J. 2018;39(33):3021–3104.
- American Diabetes Association. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes 2019. Diabetes Care. 2019;42(Suppl 1):S90–S10.
- Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170(8):836–844. doi:10.1164/rccm.200401-033OC.
- O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378:1865–1876. doi:10.1056/NEJMoa1715274.